FTC Wants More Info On $4.8B Roche Buy Of Swiss Gene Co.
By Nadia Dreid ( June 11, 2019, 1:15 PM EDT) -- The Federal Trade Commission wants more information before it decides whether to sign off on Swiss pharmaceutical company Roche's $4.8 billion plan to buy gene therapy company Spark Therapeutics....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.